FDA Ends Semaglutide Shortage Listing, Contributing to Ongoing Legal Challenges

Boston Wellness News Part 2: A surprising number of people stop taking popular weight loss drugs (3/3)

Mutsuko Ohnishi, MD, Internal medicine physician in Boston, USA Continuing from the previous article, today’s topic is also about the much-talked-about weight-loss drugs. In the U.S., Novo Nordisk’s obesity treatment drug Semaglutide (brand name: Wegovy), the type 2 diabetes treatment drug with weight-loss effects Semaglutide (brand name: Ozempic, with a lower dose of Semaglutide than Wegovy), and Eli Lilly’s type 2 diabetes treatment drug with …

FDA sued over ‘reckless and arbitrary’ semaglutide decision

The Outsourcing Facilities Association, a Texas-based trade group, is alleging that supply issues still remain for Ozempic and Wegovy. The group believes the FDA has ignored those issues.

FDA Ends Semaglutide Shortage Listing, Contributing to Ongoing Legal Challenges

Pharmacies could still experience localized availability issues for semaglutide despite its removal from the drug shortage list.